Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

35.74
Delayed Data
As of Feb 12
 +1.49 / +4.35%
Today’s Change
30.93
Today|||52-Week Range
77.80
-42.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues84.9M62.6M120.4M49.1M
 
 
 
 
 
Depreciation And Amortization2.4M2.4M2.6M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses72.4M69.6M73.1M94.6M
 
 
 
 
 
Research And Development67.4M63.9M67.5M88.0M
 
 
 
 
 
Total Operating Expenses74.8M71.9M75.8M97.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income10.1M-9.3M44.6M-48.1M
 
 
 
 
 
Extraordinary Charge-8.3M0.000.000.00
 
 
Interest Expense On Debt7.3M9.0M9.1M9.2M
 
 
 
 
 
Other Expenses20.5M0.001.0K20.4M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income15.6M-17.5M36.4M-35.8M
 
 
 
 
 
Income Taxes-15.4M-789.0K-789.0K0.00
 
 
 
 
Net Income31.1M-16.7M35.6M-35.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS118.2M118.9M119.7M120.0M
 
 
 
 
 
Shares To Calculate EPS Diluted122.8M118.9M127.8M120.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.25-$0.14$0.29-$0.30
 
 
 
 
 
EPS Diluted$0.25-$0.14$0.29-$0.30